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resectability. In patients in whom the obstruction is
unresectable because of anatomic limitations, metastat-
ic disease, or overall medical condition, endoscopic
techniques are minimally invasive and can provide sig-
nificant palliation. Although the long-term outlook in
these cases is often dismal, the temporary or permanent
relief of airway obstruction provides significant pallia-
tion with marked improvement in quality of life and, in
many cases, prolongation of life.
The essential principles of endoscopic management
of malignant airway obstruction have been outlined
concisely by Mathisen and Grillo.1 Advances in airway
prosthetics have provided a variety of silicone stents,
expandable metal stents, and pneumatic dilators,
enabling the surgeon to correct increasingly complex
anatomic problems. Several series have been published
describing the application and results of these tech-
niques.1-4
Because of the relative rarity of airway stenoses and
the infrequent consideration of surgical or endoscopic
C entral airway obstruction produces symptoms ofdyspnea, stridor, and obstructive pneumonia and is
frequently life-threatening, with patients having
impending suffocation. In most cases, resection and
surgical reconstruction provides the best opportunity
for definitive management. However, bronchoscopic
management is the first step in providing a diagnosis,
stabilizing the obstructed airway, and evaluating
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BRONCHOSCOPIC MANAGEMENT OF CENTRAL AIRWAY OBSTRUCTION
palliation by primary or specialty physicians, it is
uncommon to see a significant number of these prob-
lems in a thoracic surgical practice. With the establish-
ment of an endoscopic and surgical airway practice at
the University of Washington in 1992, the Thoracic
Surgical Service has received an increasing number of
referrals for the management of central airway obstruc-
tion. We have reviewed our experience in a consecutive
series of 97 patients treated with therapeutic bron-
choscopy to delineate the etiology of central airway
obstruction and results of airway therapeutics.
Patients and methods
Patients. The patient group consisted of 97 consecutive
patients seen with symptomatic central airway obstruction
between July 1992 and April 1996. Patients were included if
they underwent bronchoscopic treatment for obstruction of
the central airways, defined as the trachea, carina, right or left
main-stem bronchus, or the bronchus intermedius. Inter-
ventions included dilation, core-out of tumor, laser ablation,
stenting, and high-dose intraluminal radiation (brachythera-
py). Diagnostic examination with a flexible or rigid broncho-
scope without therapeutic interventions was excluded. All
procedures were done at the University of Washington
Medical Center in Seattle.
Preoperative management. Prereferral radiologic studies
(chest radiograph and chest computed tomography) along
with a careful history and physical examination and the refer-
ring physician’s bronchoscopy report were reviewed to deter-
mine which symptoms were attributable to airflow obstruc-
tion versus secondary pathologic conditions such as
atelectasis or pneumonia. Flexible bronchoscopes were
avoided in the evaluation of critically narrowed airways
because of the potential for occlusion of the remaining lumen,
with no ability to control the airway or to ventilate the lung
through the bronchoscope. Patients with severe stridor had
institution of medical measures for temporary stabilization of
the condition, with inspired cool saline mist, nebulized
racemic epinephrine, mild sedation, and systemic steroids.
Anesthetic technique. The surgeon was at the bedside for
the entire induction sequence and was prepared for emer-
gency airway control with the rigid bronchoscope. Careful
preoperative planning and intraoperative communication
between the surgeon and anesthesiologist were emphasized,
along with training of a dedicated team of nurses and anes-
thesiologists familiar with the problems and equipment used
for endoscopic airway management. Anesthetic induction
maintained spontaneous ventilation with the use of a combi-
nation of inhaled or short-acting intravenous agents until a
secure airway could be established.5 In cases in which the
Nd:YAG laser was used, the inspired oxygen fraction was
maintained at less than 50% to avoid combustion within the
airway.
Bronchoscopy. Rigid bronchoscopy was done with a Storz
(Shapshay laser broncho-tracheoscope, Karl Storz Endoscopy
America, Inc, Culver City, Calif) or Jackson (Pilling-Weck,
Research Triangle, NC) bronchoscope. Appropriately sized
Jackson bronchoscopes (3.5, 4, 5, 6, 7, 8, and 9 mm) were
used for initial dilation and airway control. The Jackson bron-
choscopes have the advantage of a blunt, rounded tip, making
it easier to use them for dilation with less risk of perforation
or mucosal laceration. The Storz bronchoscope has no inter-
nal light carrier, a smooth inner lumen, and multichanneled
attachments, ideal for use of the laser and for placement of
smaller (<14 mm) stents through the lumen of the broncho-
scope. Endoscopic magnification was provided by a tele-
scope (Hopkins straight-forward telescope; Karl Storz
Endoscopy America) attached to a video monitor to provide
visualization for the whole surgical team and to aid in resi-
dent education. Measurements of the length of the lesion
were recorded, as well as its relation to the vocal cords,
cricoid, carina, and lobar orifices.
Dilation. Dilation was used primarily for benign airway
stenosis. After inspection and measurement, serial dilation
was done with successively larger bronchoscopes. Steady
rotating pressure with the blunt-tipped Jackson broncho-
scopes provided passage with minimal mucosal trauma and
risk of perforation. The result was inspected, and the proce-
dure was repeated with the next larger bronchoscope until an
adequate airway caliber had been established. If the lesion
was too stenotic to accept the 3.5-mm Jackson bronchoscope,
then esophageal bougies (Jackson flexible, Karl Storz
Endoscopy America) were used to enlarge the airway enough
to allow bronchoscopic dilation. Pneumatic or hydrostatic
balloon dilation with angioplasty balloons was used whenev-
er it was necessary to dilate larger than the 8 to 9 mm possi-
ble with bronchoscopic dilation.6
Core-out. In malignant lesions the intraluminal mass was
traversed following the most normal-appearing bronchial
wall opposite the mass. In the initial examination, intentional
coring out of the tumor was not usually the objective, because
of the unknown distal anatomy. Instead, the bronchoscope
was used to press the obstruction onto its pedicle, establish-
ing control of the airway and allowing evaluation of the
extent of the pathologic condition. A mechanical core-out of
tumor was then done by engaging the endobronchial tumor
with the tip of the rigid bronchoscope and by debridement
with biopsy forceps.
Laser ablation. Laser vaporization was done predominate-
ly for residual endobronchial tumor after mechanical core-
out, for tumors inaccessible to mechanical debridement, and
occasionally for airway granulations. An Nd:YAG laser
(MBB-AT Medilas 2 Nd:YAG 621, MBB-Angewandte,
Munich, Germany) was used at a power setting of 35 watts
and 0.5-second pulse duration.
Stents. Stenting techniques were similar to those previous-
ly described in the literature.1-3,7-11 Indications for stenting
included (1) recurrent benign strictures that were not surgi-
cally resectable, (2) active inflammation or edema necessitat-
ing acute and possibly temporary support while the patholog-
ic process resolved, (3) rapidly growing or recurrent
290 Stephens and Wood The Journal of Thoracic and
Cardiovascular Surgery
February 2000
obstructive endobronchial tumors, (4) tumors producing
extrinsic obstruction, (5) early anastomotic strictures that
might stabilize over a stent during postoperative remodeling,
and (6) tracheobronchial malacia. Because stents are pallia-
tive and frequently necessitate ongoing management, they
were used only after excluding definitive surgical correction
or other, more simple, endoscopic palliation.
For simple benign and malignant stenoses the stent of
choice was a simple flanged or studded silicone stent (Hood
Laboratories, Pembroke, Mass). If the carina was involved, a
silicone Y stent was placed with a proximal tracheal limb and
bilateral main-stem bronchial limbs. If the orifice of the right
upper lobe was obstructed by a stent in the right main-stem
bronchus, it was removed and the distal end beveled slightly
before it was replaced and rechecked for lobar patency. In
cases in which the predominant pathologic condition was tra-
cheobronchial malacia the Montgomery T tube was used for
upper tracheal lesions2 and carinal Y stents for distal lesions11
(Hood Laboratories). These have the advantage of stabiliza-
tion by the T-limb through a tracheal stoma or the Y-shaped
geometry of the carina, respectively. Expandable metal stents
(Schneider Wallstent, Medinvent SA, Lausanne, Switzerland)
were also used in the setting of malacia because these stents
expand and ultimately imbed within the airway, largely pre-
venting migration.12,13 Expandable stents were also used
occasionally in the setting of difficult anatomy in which seat-
ing of the Wallstent expandable stent was more secure than
that of other stents or it provided a significantly better lumi-
nal diameter (especially for small-caliber bronchi).
Silicone stents larger than 14 mm were delivered by prepo-
sitioning a pusher tube and the stent over an appropriately
sized bronchoscope. Stents 14 mm and smaller were partial-
ly folded and introduced through the 10-mm Storz broncho-
scope. For Y stents, extra manipulations were necessary to
ensure that both limbs unfolded into the main-stem bronchi.
This was ensured by guiding 1 limb over a prepositioned bal-
loon catheter3 or by manipulating the carina of the stent with
a forceps.14 Wallstent and Permalume stents were deployed
from a flexible sheath, which permitted deployment under
combined endoscopic and fluoroscopic control.
Brachytherapy. High-dose endobronchial radiation was
used as an adjuvant therapy to core-out and stenting proce-
dures in cases with a dominant component of obstructing
endobronchial tumor. Flexible or rigid bronchoscopy guided
placement of a polyethylene afterloading catheter or catheters
into the involved airway, followed by placement of multiple
iridium-192 seeds with 1-cm spacing, calculated to produce a
dose of 1000 to 1500 cGy at 1-cm diameter from the catheter
along the course of the endobronchial tumor.
Treatment algorithm. Rigid bronchoscopy was used in all
patients with symptomatic central airway obstruction to
establish a controlled airway and to evaluate the location and
extent of pathologic conditions. Patients with resectable dis-
ease, benign or malignant, were treated by airway resection
and reconstruction. Patients with unresectable conditions
were treated according to a systematic but flexible algorithm
as shown in Fig 1. Patients with benign stenosis were treated
initially by dilation, with stents placed for rapidly recurrent or
recalcitrant strictures. Malignant obstruction was managed
primarily by a core-out of the tumor, with the use of the
Nd:YAG laser and brachytherapy as adjuncts to mechanical
débridement. Stents were placed for recurrent endobronchial
tumors or significant extrinsic compression.
Patient follow-up. Hospital records were reviewed retro-
spectively to document etiology and location of the obstruc-
tive lesions and the interventions used and to detect hospital
and outpatient deaths. Surviving patients were sought by tele-
phone inquiry. If this failed, inquiries to the referring physi-
cian were made.
Results
Patient demographics. Ninety-seven consecutive
patients underwent therapeutic bronchoscopy between
July 1992 and April 1996. There were 48 male and 49
female patients, aged 13 to 85 years. There were 20
male and 28 female patients with benign diagnoses,
aged 13 to 80 years (49 ± 17.4 years). In the malignant
group, there were 28 male and 21 female patients with
ages from 27 to 85 years (58.7 ± 12.6 years). A total of
108 stenoses were treated in the 97 patients (56 benign,
52 malignant).
Location and pathology. The locations of the
lesions treated in this study are shown in Table I.
Benign lesions more commonly involved the proximal
trachea and mid trachea with only two benign stenoses
of the distal trachea and an even distribution through-
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Fig 1. Algorithm for the endoscopic management of central
airway obstruction.
out the main-stem bronchi and bronchus intermedius.
The etiology of the benign lesions is tabulated in Table
II. The majority of benign lesions were the sequelae of
tracheostomy, prolonged intubation, or airway anasto-
mosis, and there were a number of miscellaneous caus-
es. Four patients had major airway obstruction caused
by massive pulmonary artery dilation as a result of con-
genital heart disease. Another distinct group of patients
comprised the 4 who had malacia of the trachea or
bronchus. The endoscopic findings in these cases
included a loss of structural rigidity resulting in
dynamic inspiratory collapse. The precise cause was
known in only 1 of these cases, and this was relapsing
polychondritis.
The etiology of the malignant lesions is tabulated in
Table III. Fifty-five percent (27/49) of these lesions
were a result of primary tracheobronchial or lung
tumors. The majority of these were caused by central
extension of bronchogenic carcinoma. Four patients
had obstructive tracheal tumors, which consisted of 1
squamous, 1 mucoepidermoid, and 2 adenoid cystic
tumors. Forty-five percent (22/49) of malignant lesions
were a result of metastatic disease to the airway or
mediastinum and these consisted mostly of renal cell
carcinoma, thyroid carcinoma, and metastatic sarcoma.
Distribution of procedures. A therapeutic bron-
choscopy procedure was defined as a single trip to the
operating room for treatment of an obstructing lesion.
An intervention was defined as a discrete operative
technique applied to a lesion. For example, if a malig-
nant lesion was cored out for treatment of an endolu-
minal mass and then stented for residual extrinsic com-
pression, this would represent 1 procedure consisting
of 2 discrete interventions. The 97 patients underwent
a total of 199 procedures with 338 interventions. Of
these 338 procedures, 250 were endoscopic manipula-
tions of the airway (Table IV) and 88 were stent place-
ment, removal, or revision.
Stents. Seventy-one of the stents placed were simple
292 Stephens and Wood The Journal of Thoracic and
Cardiovascular Surgery
February 2000
Table I. Location of lesions
Location Benign Malignant Total
Proximal trachea 18 3 21
Mid trachea 9 5 14
Distal 2 5 7
Left main stem 12 8 20
Right main stem 6 9 15
Bronchus intermedius 8 16 24
Lobar bronchi 1 6 7
Total 56 52 108
Table II. Etiology of benign lesions
Etiology No.
Anastomotic 14
Tracheostomy 9
Tracheal intubation 7
Vascular compression 4
Tracheomalacia 4
Idiopathic 4
Other 6
Total 48
Table III. Etiology of malignant lesions
Etiology No.
Primary tracheobronchial or lung tumors
Non–small cell lung cancer 20
Small cell lung cancer 1
Primary tracheal tumor 4
Bronchial carcinoid 2
Total 27
Distant primary tumors metastatic to trachea 
or mediastinum
Renal cell 8
Thyroid 5
Metastatic sarcoma 3
Carcinoid 1
Cervix 1
Colon 1
Peripheral neuroectodermal tumor 1
Prostate 1
Head and neck 1
Total 22
Total 49
Table IV. Distribution of interventions, excluding
stents
Procedure Benign Malignant Total
Core-out 19 43 62
Bronchoscopic dilation 68 43 111
Balloon dilation 5 0 5
Bougie dilation 17 2 19
Brachytherapy 0 9 9
Laser ablation 11 33 44
Table V. Stent use
Type of stent Benign Malignant Total
Simple 46 25 71
T, Y, or tracheostomy 9 2 11
Expandable metal 1 5 6
flanged or studded silicone stents. Eleven stents were
of a more complex design such as a T or Y configura-
tion. The distribution between groups is shown in Table
V. In the benign group, 3 Y stents, 4 T tubes, and 2 tra-
cheostomy appliances were used. In the malignant
group, 2 Y stents were used, not for carinal or bilateral
involvement, but because of proximal unilateral main-
stem bronchus involvement where simple stent place-
ment appeared insecure. Expandable stents were used
in 6 patients, mostly in cases of malignant disease in
which the anatomy interfered with adequate seating or
patency of the silicone stents.
Palliation of obstruction. Successful palliation was
achieved in 91 (94%) of 97 patients. This required mul-
tiple procedures in 41 patients and more than 1 inter-
vention per procedure in many patients to obtain or
maintain the desired result. It was not possible to palli-
ate the airway obstruction in 6 patients because of
impassable obliteration of the lumen or distal extension
into lobar or segmental bronchi.
Deaths and complications. Two deaths (2%)
occurred during the same hospital admission or within
30 days of the procedure. No deaths occurred intraoper-
atively. There were 34 known late deaths. Of the 16
patients with a known date of death, the survival after
airway intervention ranged from 1 week to 31 months,
with a mean of 7.6 months. All but 5 of the deaths were
in the malignant group. Two patients with airway com-
promise from pulmonary artery dilation who received
silicone stents died of uncontrollable airway hemor-
rhage 40 and 45 days after operation, respectively.
Autopsies failed to reveal perforation of the stent into
the pulmonary artery. Of the 3 remaining patients with
benign disease who died, 2 were lung transplant recipi-
ents who died of infectious complications and 1 was a
patient treated for a bronchial stenosis who died of com-
plications of coronary artery bypass grafting. No deaths
were attributable to obstruction of indwelling stents.
Assignment of complications is somewhat difficult in
a therapeutic modality in which transient palliation is
commonly the objective. Overall, there were 7 compli-
cations (7%). In the malignant group there were 4 com-
plications: 3 stent dislodgements necessitating replace-
ment and 1 stent occlusion by tumor. In the benign
group there were 3 complications: 2 stent migrations
necessitating repositioning and 1 stent compression
necessitating replacement with a stiffer stent.
Discussion
This series represents a single-institution experience
with the bronchoscopic management of central airway
obstruction. There are two similar series describing the
cases of patients undergoing complex bronchoscopic
management of central airway obstruction with use of a
variety of techniques.1,3 Mathisen and Grillo1 reported
on 56 patients with central airway obstruction caused by
neoplasms, and the series of Sonett and colleagues3
reported on 57 patients with central airway obstruction
with a variety of etiologies. Both of these reports
emphasized the importance of a simple but flexible and
diverse approach to these lesions, as well as the satisfy-
ing results possible from palliation of an obstructed air-
way. Other reports have focused on a single modality
therapy such as laser ablation or stenting.7,10,11,14-16
However, this is a heterogeneous patient population
with wide variability in the severity of the condition, eti-
ology, and anatomic obstacles producing airway com-
promise. Our goal has been to approach these cases with
a diversity of techniques as part of a dedicated tracheo-
bronchial surgical program. This series of 97 consecu-
tive patients achieves similar results to those of earlier
series, emphasizes the diverse pathology of these
lesions, and corroborates our clinical impression that
patients receive significant symptomatic relief from a
systematic approach to these problems.
Bronchoscopic management of airway obstruction is
almost always palliative and should only be considered
when a definitive approach is not feasible. Because it is
a palliative procedure, repeated interventions often are
required to maintain airway patency. Forty-one patients
(42%) required more than 1 procedure to obtain or
maintain airway patency, with some patients requiring
as many as 15 separate procedures. Analysis of the
pathologic conditions involved further supports the pal-
liative nature of most endobronchial interventions.
Benign postintubation, anastomotic, and postinflam-
matory stenoses result in a full-thickness fibrous scar.
Although dilation or laser “resection” might produce a
temporary improvement in airway symptoms, these
treatments usually produce further inflammation with
recurrent stenosis that, after repeated procedures, might
become more severe than the original lesion. Stenting
for benign or malignant lesions is clearly without cura-
tive intent and requires long-term management to cor-
rect potential stent problems, such as migration or
obstruction by inspissated secretions, granulation tis-
sue, or tumor. Stents might also erode into surrounding
structures, with possible exsanguinating hemorrhage
from bronchovascular fistulas.17 We encountered 2
cases of fatal hemorrhage after placement of silicone
stents. Both occurred in the setting of severe pul-
monary hypertension. There was no autopsy evidence
of a bronchopulmonary artery fistula or stent erosion in
these cases, which were both diagnosed as hemoptysis
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as a result of pulmonary hypertension. However, we
remain cautious about the use of stents for vascular air-
way compression because of the concern regarding fis-
tula formation and fatal airway hemorrhage.17
Although airway resection and reconstruction is the
preferred therapy for both benign and malignant
lesions,18,19 a variety of factors including a long steno-
sis, failed previous repair, metastatic or unresectable
malignancy, or patient refusal might dictate nonsurgical
management. In other cases, endoscopic management
might act as temporizing palliation while the patient’s
condition is stabilized or evaluated for subsequent
resection. Experience with interventional bron-
choscopy is an important part of any thoracic surgical
program that performs airway resections or lung trans-
plantation, providing for management of postoperative
anastomotic complications. The surgeon or pulmonolo-
gist considering bronchoscopic palliation should like-
wise be experienced with both the indications and tech-
niques of airway resection or be a part of a closely
linked multidisciplinary team that allows a balanced
consideration of airway resection versus therapeutic
bronchoscopy.
The algorithm used in this series tackles each unique
problem—pedunculated tumor, scar, external airway
compression, or circumferential tumor—with a cus-
tomized set of techniques. Malignant endoluminal
obstruction is cored out and the base or difficult-to-
reach remnants vaporized by the Nd:YAG laser.
Adjuvant brachytherapy is used to prolong patency in
cases of predominant endobronchial tumor or limited
extrabronchial disease. The effective dose diameter of
endobronchial radiation is 0.5 to 2.0 cm and so is not
effective treatment for bulky tumors or those producing
extrinsic compression.20 If the endobronchial disease
has been or appears likely to be rapidly recurrent, or if
significant endobronchial compression remains, an
endobronchial stent is placed. In most cases, a solid sil-
icone stent can be seated securely, which has the com-
bined advantages of being inexpensive and being easi-
ly repositioned, replaced, or removed. This is
particularly important if the indications for stenting are
possibly temporary, as in malignant disease during
therapy and in benign disease while short-term remod-
eling or resolution of inflammation occur. Expandable
wire mesh stents are chosen when it is not possible to
adequately seat a silicone stent or in cases with severe
external compression that causes distortion and persis-
tent obstruction of a silicone stent. When expandable
stents are chosen, the silicone-covered stents are pre-
ferred to avoid tumor ingrowth or granulations through
the interstices of the stent. Photodynamic therapy
(PDT) has been used in some centers for malignant air-
way obstruction and involves a photosensitizing agent
that, when exposed to light in the proper wavelength,
forms toxic oxygen radicals that result in cell death.
PDT is not widely available, in contrast to the other
techniques described for airway palliation, and its use
in the lung has been described primarily for the treat-
ment of superficial squamous carcinomas involving the
central airways.21 However, PDT has also been used in
several centers for the treatment of obstructing tracheo-
bronchial tumors and has been found to have the best
response in polypoid tumors with a poor response in
submucosal or peribronchial disease.22 Although PDT
might prove to have a significant therapeutic role in
certain superficial inoperable lung cancers, it does not
appear to provide any significant advantages in the pal-
liation of obstructing lesions over the techniques of
core-out, laser ablation, and stenting, which avoid the
consequences of photosensitivity in patients undergo-
ing PDT.
Benign strictures are dilated with esophageal bou-
gies, the bronchoscope, or appropriately sized angio-
plasty balloons. Recurrent unresectable benign stric-
ture is an indication for endoluminal stenting. Lesions
that extend proximally into the subglottic larynx usual-
ly necessitate use of a silicone stent with an external
limb (T tube) to allow stabilization of the subglottic or
supraglottic stent. Expandable stents are relatively con-
traindicated in this position because of their perma-
nence and the difficulties with proximal subglottic
granulations that might extend the original obstruction.
In cases of benign tracheobronchial malacia, silicone
stents are difficult to seat adequately and in these
patients stabilization of the stent by an external limb (T
tube), by the geometry of a carinal Y stent, or by place-
ment of an expandable stent may be required.
Although the skills and procedures described for
therapeutic bronchoscopy are not particularly difficult,
application of these skills in the patient with a severely
compromised airway is challenging, even for physi-
cians with significant experience in airway therapeu-
tics. Because of the paramount importance of the air-
way, the learning curve can be hazardous, especially in
unstable situations. Successful procedures rely heavily
on both volume and an experienced team of anesthesi-
ologists and nurses. This systematic approach also aids
in the instruction of thoracic surgical residents.
Bronchoscopic therapeutics are safe and effective
when applied to central airway obstructions from a
variety of causes. In only 6 instances in this series was
the objective of restoring airway patency technically
impossible. This was due to either obliteration of the
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lumen by impenetrable postsurgical scar or diffuse
stenosis extending into the lobar and segmental
bronchi. The insurmountable problem was identified in
each case and the procedure terminated without techni-
cal misadventure. In the remaining cases, initial
improvement was achieved anatomically and, with few
exceptions, symptomatically.
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Discussion
Dr Richard G. Fosburg (Del Mar, Calif). You mention
that your facility has become a referral center, and I think this
is insightful into what might be considered a center of excel-
lent patient care. The opportunities for disaster are very high
in attempting to correct these problems without adequate
experience and a team approach involving the anesthesiolo-
gist, the surgeon, and the diagnostic evaluations that are done
to identify the problems. There is a similar endoscopic center
in San Diego, and most of the patients in our community are
referred to that center. 
One of the things that stands out in your report is the expe-
rience with stents. Your slides indicate that you have placed
close to 80 stents. What has been the rate of retention and
extraction, and what has been the usefulness of the stenting
process itself? Could you address your remarks to those with
anastomotic strictures?
Dr Stephens. Regarding the anastomotic strictures, during
the time in which this study was conducted, amassing our
lung transplantation, tracheal resection, and bronchoplastic
resections, there were 120 anastomoses potentially at risk for
stenosis. From that number, there were a total of 9 complica-
tions, 5 of which were minor, such as suture granuloma or a
small amount of bleeding. There were 4 major complications,
specifically tight strictures that required stenting and dilation.
We are not displeased with that complication rate (3.3%) for
our anastomoses. We believe that there is a potential applica-
tion for stenting. If these cases are recognized early during
the phase of wound healing, before firm circumferential scar
has occurred, there is a possibility that stent placement may
permit tracheobronchial remodeling and the avoidance of the
need for a stent. Regarding stent placement in general, we
believe that the stent should be reserved as a last resort for
those stenoses that are not treatable without the placement of
an artificial device. The reason for that belief is that stents
have their own set of complications and are somewhat labor
intensive devices to maintain. The ridges on the stent are tur-
bulence generators. They act to retain secretions. If we do not
choose exactly the correct size of stent or if the airway
becomes less edematous and allows the stent to loosen, it can
migrate and become repositioned. Once in awhile, the patient
will actually cough the stent out. If that happens, it is usually
because the stent is not needed anymore, so that is not always
an adverse outcome. However, the rate of stent migration and
the rate of stent manipulation is about 5% in both the malig-
nant and the benign groups.
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Dr Fosburg. You use of the terms “malignant” and
“benign.” I have a suggestion. Perhaps you would consider
the idea that these conditions all are malignant in nature
because they place the patient at significant risk. Because of
our litigious society, it might be better to label them as neo-
plastic and non-neoplastic so that we do not attempt to imply
that this is a benign condition or one that is not fraught with
problems.
Dr Arthur Thomas (San Francisco, Calif). I was a bit sur-
prised at the number of strictures you had from tracheostomy
stomas, tracheomalacia, and benign cicatricial strictures. We
at San Francisco General Hospital almost never see these
complications because of low-pressure cuff tubes. We are
very comfortable in leaving a tracheal tube in place in
patients in the intensive care unit for 2 to 3 months before
conversion to tracheostomy. Do you have any thoughts on
why you have so many of these, or are they referral cases?
Dr Stephens. They have been accrued from a fairly wide
referral network. Because of our location in Seattle, our refer-
ral network covers parts of Washington, Alaska, Montana,
and Idaho. The numbers surprised us because they were larg-
er than we had expected. However, given the fact that once
those problems are detected they seem to be sent our way for
management, we are not too surprised. Some of the causes
are more surprising than the numbers themselves. For exam-
ple, one of the more interesting cases was that of a 15-year-
old girl who was in a pedestrian-versus-motorcycle crash as
an infant and apparently had complete disruption of the left
main-stem bronchus at that time. She was essentially living
with a functional pneumonectomy for several years with a
chronic cough until she was referred to us. A ventilation/per-
fusion scan showed almost zero ventilation on the affected
side. After undergoing bronchoscopic dilation, she underwent
a curative resection and had near equilibration of ventilation
and perfusion on the two sides. I think that is a testimony to
the oddity of some of the benign stenoses that we see.
Included in the miscellaneous category of benign stenoses
were such things as a near-obstructing pyogenic granuloma,
which our pathologists had a very hard time identifying any-
where else in the literature, and tuberculous lymphadenopa-
thy of such severity that it was compressing the carina and the
right main-stem bronchus, as well as some of the more distal
airways. I think the prominence of the benign stenoses that
you aptly pointed out is due partially to my lumping them
together under a miscellaneous category for the purposes of
brevity.
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